Email updates

Keep up to date with the latest news and content from BMC Infectious Diseases and BioMed Central.

This article is part of the supplement: Abstracts from the First International Science Symposium on HIV and Infectious Diseases (HIV SCIENCE 2012)

Open Access Poster presentation

Development of a vaccine delivery system using hepatitis B core antigen based VLPs to deliver mycobacterial antigens

Dhananjayan Dhanasooraj, R Ajay Kumar and Sathish Mundayoor*

Author Affiliations

Mycobacterium Research Group, Rajiv Gandhi Centre for Biotechnology, Thiruvananthapuram, Kerala, India

For all author emails, please log on.

BMC Infectious Diseases 2012, 12(Suppl 1):P9  doi:10.1186/1471-2334-12-S1-P9

Published: 4 May 2012

First paragraph (this article has no abstract)

Growing prevalence of TB and the emergence of XDR-TB have stimulated substantial efforts to develop better vaccines for TB. Recent researches have shown that some of the antigenic proteins and fusion of different proteins produced by Mycobacterium tuberculosis can give protection in animal models when administrated with specific adjuvants. In the present study, we explored the use HBcag-VLPs for delivery of tuberculosis antigens.